William Creasman to Carcinoma
This is a "connection" page, showing publications William Creasman has written about Carcinoma.
Connection Strength
3.170
-
Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource Countries. Am J Clin Oncol. 2016 Feb; 39(1):92-7.
Score: 0.464
-
Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009 May; 105(2):109.
Score: 0.289
-
Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S105-43.
Score: 0.244
-
Carcinoma of the vulva. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:7-26.
Score: 0.197
-
Carcinoma of the vagina. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:27-39.
Score: 0.197
-
Carcinoma of the corpus uteri. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:79-118.
Score: 0.197
-
Gestational trophoblastic diseases. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:167-74.
Score: 0.197
-
The National Cancer Data Base report on early stage invasive vulvar carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1997 Aug 01; 80(3):505-13.
Score: 0.129
-
Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial. J Natl Cancer Inst. 2015 Sep; 107(9).
Score: 0.111
-
Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial. J Clin Oncol. 1993 Aug; 11(8):1523-8.
Score: 0.098
-
Epithelial ovarian tumors of low malignant potential. Obstet Gynecol. 1991 Dec; 78(6):1027-32.
Score: 0.087
-
Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients. Cancer. 1991 Jul 15; 68(2):269-71.
Score: 0.085
-
Prognostic factors in relation to second-look laparotomy in ovarian cancer. Baillieres Clin Obstet Gynaecol. 1989 Mar; 3(1):183-90.
Score: 0.072
-
Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S145-60.
Score: 0.061
-
Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S161-92.
Score: 0.061
-
Carcinoma of the vagina. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S29-42.
Score: 0.061
-
Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S43-103.
Score: 0.061
-
Carcinoma of the vulva. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006 Nov; 95 Suppl 1:S7-27.
Score: 0.061
-
Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol. 1985 Sep 15; 153(2):164-72.
Score: 0.056
-
Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: a Gynecologic Oncology Group Study. Am J Obstet Gynecol. 1985 Jun 15; 152(4):418-23.
Score: 0.056
-
Computed tomography in evaluation of extrapelvic lymphadenopathy in carcinoma of the cervix. Obstet Gynecol. 1985 Jan; 65(1):73-6.
Score: 0.054
-
Carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:41-78.
Score: 0.049
-
Carcinoma of the Fallopian tube. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:119-33.
Score: 0.049
-
Carcinoma of the ovary. Int J Gynaecol Obstet. 2003 Oct; 83 Suppl 1:135-66.
Score: 0.049
-
Stage I borderline ovarian tumors. Obstet Gynecol. 1982 Jan; 59(1):93-6.
Score: 0.044
-
The National Cancer Data Base report on cancer of the vagina. Cancer. 1998 Sep 01; 83(5):1033-40.
Score: 0.035
-
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 1994 Apr; 170(4):974-9; discussion 979-80.
Score: 0.026
-
Carcinoma in situ of the cervix. An analysis of 861 patients. Obstet Gynecol. 1972 Mar; 39(3):373-80.
Score: 0.022
-
Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989 Apr; 33(1):68-70.
Score: 0.018
-
Cytopathology and the management of early invasive cancer of the uterine cervix. Obstet Gynecol. 1982 Sep; 60(3):350-3.
Score: 0.011
-
The abnormal Pap smear--what to do next? Cancer. 1981 Jul 15; 48(2 Suppl):515-22.
Score: 0.011
-
Management of early cervical neoplasia. Clin Obstet Gynecol. 1975 Sep; 18(3):233-45.
Score: 0.007
-
Unreliability of urinary cytology in detecting gynecologic malignancy. Cancer. 1972 Jul; 30(1):148-9.
Score: 0.006
-
Role of the fallopian tube in dissemination of malignant cells in corpus cancer. Cancer. 1972 Feb; 29(2):456-7.
Score: 0.005